Protocol Ledger

NCT07389109 · Phase III · ACTIVE NOT RECRUITING

A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT)

Interventional Phase III clinical trial protocol NCT07389109 sponsored by PPM Services in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-12-05 Enrollment: 400 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07389109
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)400 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07389109
Protocol FieldVerified Registry Value
NCT IdentifierNCT07389109
Consolidated Lead SponsorPPM Services
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment400 participants (ESTIMATED)
Registered Start Date2024-12-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07389109
Hospital Research SiteLocationSite Profile
Fondazione IRCCS Policlinico San MatteoPavia, ItalyOpen Hospital Dossier ->
Azienda Ospedaliera Di PadovaPadova, ItalyOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI